| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |